Cytena develops single-cell printing technology and automated solutions for cell line development, enabling the efficient production of stable cell lines for therapeutic applications. Their systems streamline workflows for biopharmaceutical companies, reducing the time and cost associated with developing biologics while ensuring compliance with regulatory standards.
Funding
$3.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The development of stable cell lines for therapeutic applications is often a time-consuming and labor-intensive process, particularly within biopharmaceutical companies adhering to stringent regulatory standards. Traditional cell line development workflows involve manual, repetitive tasks that can lead to inefficiencies and increased costs.
Solution
Cytena provides automated solutions for cell line development (CLD), streamlining the production of stable cell lines for therapeutic applications. Their portfolio includes single-cell dispensers, automated cell line development platforms, microplate washers, and live cell imaging systems. These systems automate key steps in CLD workflows, such as single-cell cloning, colony outgrowth, upscaling, and master cell bank establishment. By automating these processes, Cytena enables biopharmaceutical companies, biotechs, and CDMOs to accelerate the development of stable cell lines, reduce costs, and ensure compliance with regulatory standards for therapeutic use.
Target Audience
Cytena's primary customers are biopharmaceutical companies, biotechs, and CDMOs involved in the development of therapeutic antibodies, viral vectors, and cell therapies.
Features
- Single-cell dispensers with patented technology for documenting monoclonality and improving workflow efficiency
- Automated cell line development platforms for faster, more accurate, and affordable therapy development
- Microplate washers and dispensers for speeding up workflows without sacrificing reproducibility
- Live cell imaging and analysis solutions for real-time monitoring of cell kinetics
- Microbioreactors for high-throughput cell culture
- Reagents and consumables for real-time cytotoxicity identification
- C.STATION™ for combining single-cell cloning, upscaling, and clone selection in one unit
- UP.SIGHT™ platform with dual imaging system for double assurance of monoclonality during single-cell isolation
- I.DOT non-contact dispensing technology for accelerating liquid handling and sample preparation
- C.WASH platform using centrifugal force to wash plates, reducing hands-on time and resources needed to purify samples